Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- University of Southern California
- Study ID
- NCT07456436
- Status
- Recruiting
Conditions
- Hematopoietic and Lymphatic System Neoplasm
- Malignant Solid Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Non-Interventional Study — OTHERNon-interventional study
Study Details
This study assesses patient awareness and understanding of cancer clinical trials.
Key Dates
- Start date
- Nov 26, 2024
- Status verified
- Mar 2026
- Primary completion
- Nov 26, 2026
- Completion
- Nov 26, 2027
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: ObservationalPatients review educational materials and complete surveys on study.
Primary Outcome Measure
Change in Baseline Survey Score [ Time Frame: Through study completion, up to 1 year ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| USC / Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | Chanita Hughes-Halbert (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Los Angeles, CA
By research site
Related Studies
- Project: Every Child for Younger Patients With CancerRecruiting · Children's Oncology Group · Birmingham, Alabama
- Collection and Storage of Tissue and Blood Samples From Patients With CancerRecruiting · National Cancer Institute LAO · Birmingham, Alabama
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid TumorsRecruiting · SWOG Cancer Research Network · Anchorage, Alaska